These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 30829570)

  • 1. A novel L1CAM isoform with angiogenic activity generated by NOVA2-mediated alternative splicing.
    Angiolini F; Belloni E; Giordano M; Campioni M; Forneris F; Paronetto MP; Lupia M; Brandas C; Pradella D; Di Matteo A; Giampietro C; Jodice G; Luise C; Bertalot G; Freddi S; Malinverno M; Irimia M; Moulton JD; Summerton J; Chiapparino A; Ghilardi C; Giavazzi R; Nyqvist D; Gabellini D; Dejana E; Cavallaro U; Ghigna C
    Elife; 2019 Mar; 8():. PubMed ID: 30829570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual REST-dependence of L1CAM: from gene expression to alternative splicing governed by Nova2 in neural cells.
    Mikulak J; Negrini S; Klajn A; D'Alessandro R; Mavilio D; Meldolesi J
    J Neurochem; 2012 Mar; 120(5):699-709. PubMed ID: 22176577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative Splicing by NOVA Factors: From Gene Expression to Cell Physiology and Pathology.
    Meldolesi J
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Expression Profiles Controlled by the Alternative Splicing Factor Nova2 in Endothelial Cells.
    Belloni E; Di Matteo A; Pradella D; Vacca M; Wyatt CDR; Alfieri R; Maffia A; Sabbioneda S; Ghigna C
    Cells; 2019 Nov; 8(12):. PubMed ID: 31771184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative Splicing Changes Promoted by NOVA2 Upregulation in Endothelial Cells and Relevance for Gastric Cancer.
    Di Matteo A; Belloni E; Pradella D; Chiaravalli AM; Pini GM; Bugatti M; Alfieri R; Barzan C; Franganillo Tena E; Bione S; Terenzani E; Sessa F; Wyatt CDR; Vermi W; Ghigna C
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The soluble form of the cancer-associated L1 cell adhesion molecule is a pro-angiogenic factor.
    Friedli A; Fischer E; Novak-Hofer I; Cohrs S; Ballmer-Hofer K; Schubiger PA; Schibli R; Grünberg J
    Int J Biochem Cell Biol; 2009 Jul; 41(7):1572-80. PubMed ID: 19401151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A ligand-insensitive UNC5B splicing isoform regulates angiogenesis by promoting apoptosis.
    Pradella D; Deflorian G; Pezzotta A; Di Matteo A; Belloni E; Campolungo D; Paradisi A; Bugatti M; Vermi W; Campioni M; Chiapparino A; Scietti L; Forneris F; Giampietro C; Volf N; Rehman M; Zacchigna S; Paronetto MP; Pistocchi A; Eichmann A; Mehlen P; Ghigna C
    Nat Commun; 2021 Aug; 12(1):4872. PubMed ID: 34381052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Alternative Splicing Regulator Nova2 Constrains Vascular Erk Signaling to Limit Specification of the Lymphatic Lineage.
    Baek S; Oh TG; Secker G; Sutton DL; Okuda KS; Paterson S; Bower NI; Toubia J; Koltowska K; Capon SJ; Baillie GJ; Simons C; Muscat GEO; Lagendijk AK; Smith KA; Harvey NL; Hogan BM
    Dev Cell; 2019 Apr; 49(2):279-292.e5. PubMed ID: 31014480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The alternative splicing factor Nova2 regulates vascular development and lumen formation.
    Giampietro C; Deflorian G; Gallo S; Di Matteo A; Pradella D; Bonomi S; Belloni E; Nyqvist D; Quaranta V; Confalonieri S; Bertalot G; Orsenigo F; Pisati F; Ferrero E; Biamonti G; Fredrickx E; Taveggia C; Wyatt CD; Irimia M; Di Fiore PP; Blencowe BJ; Dejana E; Ghigna C
    Nat Commun; 2015 Oct; 6():8479. PubMed ID: 26446569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brief report: L1 cell adhesion molecule, a novel surface molecule of human embryonic stem cells, is essential for self-renewal and pluripotency.
    Son YS; Seong RH; Ryu CJ; Cho YS; Bae KH; Chung SJ; Lee B; Min JK; Hong HJ
    Stem Cells; 2011 Dec; 29(12):2094-9. PubMed ID: 21957033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Pleiotropic Role of L1CAM in Tumor Vasculature.
    Angiolini F; Cavallaro U
    Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28134764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential NOVA2-Mediated Splicing in Excitatory and Inhibitory Neurons Regulates Cortical Development and Cerebellar Function.
    Saito Y; Yuan Y; Zucker-Scharff I; Fak JJ; Jereb S; Tajima Y; Licatalosi DD; Darnell RB
    Neuron; 2019 Feb; 101(4):707-720.e5. PubMed ID: 30638744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of the alternative splicing factor NOVA2 in colorectal cancer vasculature.
    Gallo S; Arcidiacono MV; Tisato V; Piva R; Penolazzi L; Bosi C; Feo CV; Gafà R; Secchiero P
    Onco Targets Ther; 2018; 11():6049-6056. PubMed ID: 30275709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L1 Cell Adhesion Molecule in Cancer, a Systematic Review on Domain-Specific Functions.
    Maten MV; Reijnen C; Pijnenborg JMA; Zegers MM
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31455004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L1 cell adhesion molecule as a therapeutic target in cancer.
    Yu X; Yang F; Fu DL; Jin C
    Expert Rev Anticancer Ther; 2016; 16(3):359-71. PubMed ID: 26781307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L1CAM-integrin interaction induces constitutive NF-kappaB activation in pancreatic adenocarcinoma cells by enhancing IL-1beta expression.
    Kiefel H; Bondong S; Erbe-Hoffmann N; Hazin J; Riedle S; Wolf J; Pfeifer M; Arlt A; Schäfer H; Müerköster SS; Altevogt P
    Oncogene; 2010 Aug; 29(34):4766-78. PubMed ID: 20543863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De Novo Frameshift Variants in the Neuronal Splicing Factor NOVA2 Result in a Common C-Terminal Extension and Cause a Severe Form of Neurodevelopmental Disorder.
    Mattioli F; Hayot G; Drouot N; Isidor B; Courraud J; Hinckelmann MV; Mau-Them FT; Sellier C; Goldman A; Telegrafi A; Boughton A; Gamble C; Moutton S; Quartier A; Jean N; Van Ness P; Grotto S; Nambot S; Douglas G; Si YC; Chelly J; Shad Z; Kaplan E; Dineen R; Golzio C; Charlet-Berguerand N; Mandel JL; Piton A
    Am J Hum Genet; 2020 Apr; 106(4):438-452. PubMed ID: 32197073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EMT-associated up-regulation of L1CAM provides insights into L1CAM-mediated integrin signalling and NF-κB activation.
    Kiefel H; Bondong S; Pfeifer M; Schirmer U; Erbe-Hoffmann N; Schäfer H; Sebens S; Altevogt P
    Carcinogenesis; 2012 Oct; 33(10):1919-29. PubMed ID: 22764136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L1CAM increases MAP2 expression via the MAPK pathway to promote neurite outgrowth.
    Poplawski GH; Tranziska AK; Leshchyns'ka I; Meier ID; Streichert T; Sytnyk V; Schachner M
    Mol Cell Neurosci; 2012 Jun; 50(2):169-78. PubMed ID: 22503709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The intracellular domain of L1CAM binds to casein kinase 2α and is neuroprotective via inhibition of the tumor suppressors PTEN and p53.
    Wang Y; Schachner M
    J Neurochem; 2015 Jun; 133(6):828-43. PubMed ID: 25727698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.